Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03684811
Title A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Forma Therapeutics, Inc.

liver carcinoma

high grade glioma


hepatocellular carcinoma

Advanced Solid Tumor

bile duct carcinoma

biliary tract cancer

intrahepatic cholangiocarcinoma


Cisplatin + Gemcitabine + Olutasidenib

Azacitidine + Olutasidenib


Nivolumab + Olutasidenib

Age Groups: adult | senior
Covered Countries USA | FRA | ESP

Additional content available in CKB BOOST